Statistics

Total Visits

Views
Targeted suppression of AR-V7 using PIP5K1α inhibitor overcomes enzalutamide resistance in prostate cancer cells 286

Total Visits Per Month

July 2025 August 2025 September 2025 October 2025 November 2025 December 2025 January 2026
Targeted suppression of AR-V7 using PIP5K1α inhibitor overcomes enzalutamide resistance in prostate cancer cells 0 77 18 16 5 5 1

File Visits

Views
SCOPUS-2016-7-39-SID84993967394-a1.pdf 19

Top country views

Views
Russia 106

Top cities views

Views
Kazan 106

Search DSpace


Advanced Search

Browse

My Account

Statistics